| Literature DB >> 32269153 |
Yusuke Hashimoto1, Izumi Kita2, Masato Suzuki3, Hidetada Hirakawa1, Hirofumi Ohtaki2, Haruyoshi Tomita4,5.
Abstract
Vancomycin-resistant enterococci pose a threat in the clinical setting and have been linked to hospital outbreaks worldwide. In 2017, a local spread of VanA-type vancomycin-resistant enterococci (VRE) occurred in Japan, and 25 enterococcal isolates, including 14 Enterococcus faecium, 8 E. raffinosus, and 3 E. casseliflavus isolates, were identified from four inpatients. Molecular analysis of the multispecies of VanA-type VRE revealed the involvement of both the dissemination of clonally related VRE strains between patients and the horizontal transfer of plasmids harboring the vanA gene cluster between Enterococcus spp. Pulsed-field gel electrophoresis showed that the plasmid DNAs without S1 nuclease treatment were able to migrate into the gel, suggesting that the topology of the plasmid was linear. Whole-genome sequencing revealed that this plasmid, designated pELF2, was 108,102 bp long and encoded multiple antimicrobial resistance genes, including ermA and ant(9). The amino acid sequences of putative replication- and transfer-related genes were highly conserved between pELF2 and pELF1, the latter of which was the first identified enterococcal conjugative linear plasmid. On comparing the genomic structure, pELF2 showed the presence of a backbone similar to that of pELF1, especially with respect to the nucleotide sequences of both terminal ends, indicating a hybrid-type linear plasmid, possessing two different terminal structures. pELF2 possessed a broad host range and high conjugation frequencies for enterococci. The easy transfer of pELF2 to different Enterococcus spp. in vitro might explain this local spread of multiple species, highlighting the clinical threat from the spread of antimicrobial resistance by an enterococcal linear plasmid.IMPORTANCE Increasing multidrug resistance, including vancomycin resistance, in enterococci is a major concern in clinical settings. Horizontal gene transfer, such as via plasmids, has been shown to play a crucial role in the acquisition of vancomycin resistance. Among vancomycin resistance types, the VanA type is one of the most prevalent, and outbreaks caused by VanA-type vancomycin-resistant enterococci (VRE) have occurred worldwide. Here, we describe an enterococcal linear plasmid responsible for multispecies local spread of VanA-type VRE. Such a study is important because although hospital outbreaks caused by mixed enterococcal species have been reported, this particular spread indicates plasmid transfer across species. This is a crucial finding because the high risk for such a spread of antimicrobial resistance calls for regular monitoring and surveillance.Entities:
Keywords: conjugative linear plasmid; interspecies transmission; local spread; vancomycin-resistant enterococci
Mesh:
Substances:
Year: 2020 PMID: 32269153 PMCID: PMC7142295 DOI: 10.1128/mSphere.00102-20
Source DB: PubMed Journal: mSphere ISSN: 2379-5042 Impact factor: 4.389
FIG 1Bacterial strains used in this study and their pulsed-field gel electrophoresis (PFGE) patterns and drug susceptibilities. The superscript italic “a” indicates results of PFGE analysis of SmaI-digested DNA isolated from the locally spread strains. Pulse time varied from 5.3 to 34.9 s during the 20.0 h of electrophoresis. The superscript italic “b” indicates the following abbreviations and definitions: VAN, vancomycin; TEC, teicoplanin; LZD, linezolid; AMP, ampicillin; GEN, gentamicin; KAN, kanamycin; STR, streptomycin; ERY, erythromycin; CHL, chloramphenicol; TET, tetracycline; MIN, minocycline; CIP, ciprofloxacin; CRO, ceftriaxone; CMZ, cefmetazole; MEM, meropenem. To determine the MICs, E. raffinosus strains were grown for 48 h because their growth rate was low.
FIG 2Pulsed-field gel electrophoresis (PFGE) analysis of S1 nuclease-untreated DNA and Southern blotting of the locally spread strains. PFGE analysis of S1 nuclease-untreated DNA (left) and Southern hybridization with a vanA gene probe (right). Lanes: C, AA708, a control strain harboring the linear plasmid pELF1; MM, Lambda Ladder PFG Marker (New England BioLabs); 1, KUHS1; 2, KUHS2; 3, KUHS3; 4, KUHS4; 5, KUHS5; 6, KUHS6; 7, KUHS7; 8, KUHS8; 9, KUHS9; 10, KUHS10; 11, KUHS11; 12, KUHS12; 13, KUHS13; 14, KUHS14; 15, KUHS15; 16, KUHS16; 17, KUHS17; 18, KUHS18; 19, KUHS19; 20, KUHS20; 21, KUHS21; 22, KUHS22; 23, KUHS23; 24, KUHS24; 25, KUHS25.
FIG 3Schematics of the genetic structure of the vanA gene cluster (A) and pELF2 (B). The panels show the genetic structure of the vanA gene cluster carried on pELF2 (A) and a genomic comparison between pELF2 and pELF1 generated by Easyfig (B) (21). Gray lines connecting the nucleotide sequences of the two plasmids represent nucleotide identity of >67%. Arrows represent vancomycin resistance genes (orange), other drug resistance genes (red), putative replication-related genes (yellow), and putative transfer-related genes (green), respectively.